Familial hypertriglyceridemia (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Familial hypertriglyceridemia" in English language version.

refsWebsite

Global rank English rank

17nih.gov

4^th place

9doi.org

2^nd place

2semanticscholar.org

11^th place

8^th place

doi.org

Ripatti P, Rämö JT, Mars NJ, Fu Y, Lin J, Söderlund S, et al. (April 2020). "Polygenic Hyperlipidemias and Coronary Artery Disease Risk". Circulation: Genomic and Precision Medicine. 13 (2): e002725. doi:10.1161/CIRCGEN.119.002725. PMC 7176338. PMID 32154731.
Quispe R, Hendrani A, Baradaran-Noveiry B, Martin S, Brown E, Kulkarni K, et al. (2019). "Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7". Archives of Medical Science. 15 (5): 1195–1202. doi:10.5114/aoms.2019.87207. PMC 6764300. PMID 31572464. S2CID 203620865.
Hegele RA, Ban MR, Hsueh N, Kennedy BA, Cao H, Zou GY, et al. (1 November 2009). "A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia". Human Molecular Genetics. 18 (21): 4189–4194. doi:10.1093/hmg/ddp361. PMC 2758142. PMID 19656773.
Johansen CT, Wang J, Lanktree MB, McIntyre AD, Ban MR, Martins RA, et al. (August 2011). "An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of Hypertriglyceridemia". Arteriosclerosis, Thrombosis, and Vascular Biology. 31 (8): 1916–1926. doi:10.1161/ATVBAHA.111.226365. PMC 3562702. PMID 21597005. S2CID 7920385.
Triglyceride Coronary Disease Genetics Consortium Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, et al. (May 2010). "Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies". The Lancet. 375 (9726): 1634–1639. doi:10.1016/S0140-6736(10)60545-4. PMC 2867029. PMID 20452521.
"Department of Error". The Lancet. 376 (9735): 90. July 2010. doi:10.1016/S0140-6736(10)61075-6. PMC 3081093.
Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, et al. (1 September 2012). "Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline". The Journal of Clinical Endocrinology & Metabolism. 97 (9): 2969–2989. doi:10.1210/jc.2011-3213. PMC 3431581. PMID 22962670.
"Corrigenda". The Journal of Clinical Endocrinology & Metabolism. 100 (12): 4685. 1 December 2015. doi:10.1210/jc.2015-3649. PMC 5399508. PMID 26562756.
Pradhan A, Bhandari M, Vishwakarma P, Sethi R (March 2020). "Triglycerides and Cardiovascular Outcomes—Can We REDUCE-IT ?". International Journal of Angiology. 29 (1): 002–011. doi:10.1055/s-0040-1701639. PMC 7054063. PMID 32132810.

nih.gov

ncbi.nlm.nih.gov

Ripatti P, Rämö JT, Mars NJ, Fu Y, Lin J, Söderlund S, et al. (April 2020). "Polygenic Hyperlipidemias and Coronary Artery Disease Risk". Circulation: Genomic and Precision Medicine. 13 (2): e002725. doi:10.1161/CIRCGEN.119.002725. PMC 7176338. PMID 32154731.
Quispe R, Hendrani A, Baradaran-Noveiry B, Martin S, Brown E, Kulkarni K, et al. (2019). "Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7". Archives of Medical Science. 15 (5): 1195–1202. doi:10.5114/aoms.2019.87207. PMC 6764300. PMID 31572464. S2CID 203620865.
Hegele RA, Ban MR, Hsueh N, Kennedy BA, Cao H, Zou GY, et al. (1 November 2009). "A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia". Human Molecular Genetics. 18 (21): 4189–4194. doi:10.1093/hmg/ddp361. PMC 2758142. PMID 19656773.
Johansen CT, Wang J, Lanktree MB, McIntyre AD, Ban MR, Martins RA, et al. (August 2011). "An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of Hypertriglyceridemia". Arteriosclerosis, Thrombosis, and Vascular Biology. 31 (8): 1916–1926. doi:10.1161/ATVBAHA.111.226365. PMC 3562702. PMID 21597005. S2CID 7920385.
Triglyceride Coronary Disease Genetics Consortium Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, et al. (May 2010). "Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies". The Lancet. 375 (9726): 1634–1639. doi:10.1016/S0140-6736(10)60545-4. PMC 2867029. PMID 20452521.
"Department of Error". The Lancet. 376 (9735): 90. July 2010. doi:10.1016/S0140-6736(10)61075-6. PMC 3081093.
Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, et al. (1 September 2012). "Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline". The Journal of Clinical Endocrinology & Metabolism. 97 (9): 2969–2989. doi:10.1210/jc.2011-3213. PMC 3431581. PMID 22962670.
"Corrigenda". The Journal of Clinical Endocrinology & Metabolism. 100 (12): 4685. 1 December 2015. doi:10.1210/jc.2015-3649. PMC 5399508. PMID 26562756.
Pradhan A, Bhandari M, Vishwakarma P, Sethi R (March 2020). "Triglycerides and Cardiovascular Outcomes—Can We REDUCE-IT ?". International Journal of Angiology. 29 (1): 002–011. doi:10.1055/s-0040-1701639. PMC 7054063. PMID 32132810.

pubmed.ncbi.nlm.nih.gov

Ripatti P, Rämö JT, Mars NJ, Fu Y, Lin J, Söderlund S, et al. (April 2020). "Polygenic Hyperlipidemias and Coronary Artery Disease Risk". Circulation: Genomic and Precision Medicine. 13 (2): e002725. doi:10.1161/CIRCGEN.119.002725. PMC 7176338. PMID 32154731.
Quispe R, Hendrani A, Baradaran-Noveiry B, Martin S, Brown E, Kulkarni K, et al. (2019). "Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7". Archives of Medical Science. 15 (5): 1195–1202. doi:10.5114/aoms.2019.87207. PMC 6764300. PMID 31572464. S2CID 203620865.
Hegele RA, Ban MR, Hsueh N, Kennedy BA, Cao H, Zou GY, et al. (1 November 2009). "A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia". Human Molecular Genetics. 18 (21): 4189–4194. doi:10.1093/hmg/ddp361. PMC 2758142. PMID 19656773.
Johansen CT, Wang J, Lanktree MB, McIntyre AD, Ban MR, Martins RA, et al. (August 2011). "An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of Hypertriglyceridemia". Arteriosclerosis, Thrombosis, and Vascular Biology. 31 (8): 1916–1926. doi:10.1161/ATVBAHA.111.226365. PMC 3562702. PMID 21597005. S2CID 7920385.
Triglyceride Coronary Disease Genetics Consortium Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, et al. (May 2010). "Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies". The Lancet. 375 (9726): 1634–1639. doi:10.1016/S0140-6736(10)60545-4. PMC 2867029. PMID 20452521.
Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, et al. (1 September 2012). "Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline". The Journal of Clinical Endocrinology & Metabolism. 97 (9): 2969–2989. doi:10.1210/jc.2011-3213. PMC 3431581. PMID 22962670.
"Corrigenda". The Journal of Clinical Endocrinology & Metabolism. 100 (12): 4685. 1 December 2015. doi:10.1210/jc.2015-3649. PMC 5399508. PMID 26562756.
Pradhan A, Bhandari M, Vishwakarma P, Sethi R (March 2020). "Triglycerides and Cardiovascular Outcomes—Can We REDUCE-IT ?". International Journal of Angiology. 29 (1): 002–011. doi:10.1055/s-0040-1701639. PMC 7054063. PMID 32132810.

semanticscholar.org

api.semanticscholar.org

Quispe R, Hendrani A, Baradaran-Noveiry B, Martin S, Brown E, Kulkarni K, et al. (2019). "Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7". Archives of Medical Science. 15 (5): 1195–1202. doi:10.5114/aoms.2019.87207. PMC 6764300. PMID 31572464. S2CID 203620865.
Johansen CT, Wang J, Lanktree MB, McIntyre AD, Ban MR, Martins RA, et al. (August 2011). "An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of Hypertriglyceridemia". Arteriosclerosis, Thrombosis, and Vascular Biology. 31 (8): 1916–1926. doi:10.1161/ATVBAHA.111.226365. PMC 3562702. PMID 21597005. S2CID 7920385.